GE Healthcare Shares Rise After Providing 2023 Guidance
January 11 2023 - 02:31PM
Dow Jones News
By Will Feuer
Shares of GE Healthcare Technologies Inc. rose Wednesday after
the medical-technology company issued some preliminary results for
the fourth quarter and provided guidance for 2023.
The stock climbed more than 9% to $65.47 a share, making it the
top gainer in the S&P 500. It's on path to set a record close,
beating the high of $60.49 set on Jan. 4, its first day of trading,
according to Dow Jones Market Data.
The company, which completed its spinoff from General Electric
Co. last week, said Tuesday that it expects adjusted earnings
before interest and taxes margin to be 15% to 15.5% in 2023. Later,
during a presentation at the J.P. Morgan Healthcare Conference,
company executives said GE Healthcare Technologies is targeting
adjusted EBIT margin in the high-teens to 20% range on a
medium-term basis.
"We see a very clear path for our margin expansion," Chief
Financial Officer Helmut Zodl said. The company is changing how it
thinks about pricing and its front-end sales team, he said, as well
as cutting costs in some areas.
"We don't need to have a subsidiary in every country," Mr. Zodl
said. The company is also seeing signs of inflation easing, he
said.
Chief Executive Peter Arduini said the company's backlog is at
all-time levels due to a combination of supply challenges and
pent-up demand for procedures.
"One of the things that is just evident is the amount of
procedures that are actually waiting to happen around the world as
I talk to customers in all continents is actually unprecedented,"
Mr. Arduini said.
Wait times for imaging procedures have extended to months at big
institutions and hospital systems are prioritizing buying GE
Healthcare's equipment to improve productivity, he said.
The company also said Tuesday that fourth-quarter revenue was
about $4.9 billion, growth of about 12% on an organic basis, which
strips out currency fluctuations as well as recent acquisitions and
divestitures.
The company expects 2023 organic revenue to grow by 5% to 7%
from 2022 levels. In 2022, organic revenue grew by about 7%. The
company expects free-cash flow conversion of more than 85% in
2023.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
January 11, 2023 14:16 ET (19:16 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
General Electric (NYSE:GE)
Historical Stock Chart
From May 2023 to Jun 2023
General Electric (NYSE:GE)
Historical Stock Chart
From Jun 2022 to Jun 2023